Search Results

You searched for : IQVIA  

Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetes

...
Mar 20

India vs. Trump’s Pharma Tariff: The Battle Over Affordable Medicine

Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India ...
Feb 21

Glenmark Launches Zita DM: A Triple-Drug Combination for Type 2 Diabetes for just Rs 14

Glenmark's commitment to providing affordable and effective solutions highlights its role as a leader in diabetes care. As Zita DM becomes a part of ...
Oct 19

For Rs 628 crore JB Chemicals to buy brands from Sanzyme

With Rs 628 crore, the board of JB Chemicals will acquire a bunch of brands from Sanzyme Private Limited (SPL). ...
Jan 28

NirogGyan and SmartReports for India

9 in every 10 Indian qualifies with low health literacy. Despite this, NirogGyan is revolutionizing diagnostic reports to help patients take charge of their health....
Jan 28

AarogyaAI and TB treatment in India

TB is a major health problem that causes 220,000 deaths every year in India. AarogyaAI Innovations uses AI to diagnose the drug resistance in ...
Jan 12

Bionworks and the mobile-based EMR solution

One Bangalore-based company that provides AI-driven EMR Bionworks Technologies. Their product Healthplug is a multilingual patient engagement app that also improves staff collaboration ...
Oct 26

Lupin Launches Tavaborole Topical Solution in the United States

The product will be manufactured at Lupin’s facility in Pithampur, India...
Jul 14

Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg

According to IQVIATM sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales ...
Jun 25

Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution

...
Jun 23

Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.’s Brovana

Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), ...
Jun 23

Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets

Sevelamer Hydrochloride Tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis....
Jun 17

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation

Testosterone Topical Solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of ...
Jun 17

Glenmark launches Tiogiva, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler

Glenmark has launched Tiotropium Bromide Dry Powder Inhaler (DPI) under the brand name - Tiogiva in UK ...
Jun 15

Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences...
Jan 15

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ...
Jan 07

Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

Sulfamethoxazole and Trimethoprim Oral Suspension, is indicated for the treatment and prevention of a wide variety of bacterial infections....
Jan 06

Glenmark receives ANDA final approval for Tadalafil Tablets

Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals....
Dec 31

Lupin launches Meloxicam Capsules, received approval from USFDA

Meloxicam Capsules indicated for the management of osteoarthritis pain...
Dec 29

Lupin launches Meloxicam Capsules

Meloxicam Capsules is the generic equivalent of Vivlodex Capsules of Zyla Life Sciences US, Inc., and indicated for the management of osteoarthritis (OA) pain....
Dec 28

Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules

Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules...
Dec 21

Strides Pharma receives USFDA approval for Oxybutynin Chloride Tablets

The medication is used to treat overactive bladder and urinary conditions...
Dec 18

Alembic Pharmaceuticals announces USFDA Final Approval for Asenapine Sublingual Tablets

Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults....
Dec 11

We work in a digital world says Dr. Vivek Kaser, Associate Medical Data Review Manager, IQVIA

...
Dec 09

Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone Tablets USP

Alembic has a cumulative total of 137 ANDA approvals (118 final approvals and 19 tentative approvals) from USFDA...
Dec 03

25 Matching result(s) found!

-Advertisements-




Trending Now

Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025